Our Board of Trustees

Antibiotic Research UK is run by the Trustees (Chairman Designate Mr Simon Dukes), who are elected by the Members.

The charity has a Science Committee which lays out, commissions and monitors the charity’s scientific programme and the Chief Executive is Professor Colin Garner.

The organisational structure of the Charity is shown in this diagram.

Join Antibiotic Research UK today
help us save modern medicine!
organisational structure of Antibiotic Research UK

Meet Our Board of Trustees

  • Simon Dukes, Chair of Trustees Antibiotic Research UK
    Simon Dukes
    BA MBA
    Chair of Trustees (Designate)

    Simon is the Chief Executive of the Pharmaceutical Services Negotiating Committee (PSNC – www.psnc.org.uk) which is the body responsible for negotiating community pharmacy services on behalf of the country’s 11,000 community pharmacies. With over two decades working in the UK public sector, Simon has experience in a number of roles and specialisms including defence and security policy, public affairs, media and communications strategy, negotiation and cyber security. In 2013 he left HM Government to become the Chief Executive of the UK’s Fraud Prevention Service, Cifas.  There, he was on the Oversight Board of the Home Secretary’s Joint Fraud Task Force, and the Management Board of the Joint Money Laundering Intelligence Task Force.  Simon joined the Pharmaceutical Services Negotiating Committee as CEO in May 2018.  As such, he is the principal advisor to the PSNC committee, and is responsible and accountable for all operational dimensions of the organisation.  These include the planning and shaping of NHS services provided by the network of community pharmacies in England, as well as negotiating funding from HM Government.

    Simon commenting on his appointment said “I am delighted to be joining Antibiotic Research UK as Chair Designate. The coronavirus pandemic has demonstrated the impact that infectious illnesses can have on our society. The predictions of global deaths from antibiotic resistance in the decades to come put those from COVID-19 in the shade. This is why the work of Antibiotic Research UK, the only charity in the UK dedicated to fighting antimicrobial resistance, is so important. I look forward to working with the Trustee Board and Chief Executive to help ANTRUK realise its ambitious plans in antimicrobial research, education and patient support.”

  • Professor Colin Garner PhD DSc FRCPath (Chief Executive)
    Professor Colin Garner
    BPharm PhD DSc FRCPath
    Ex-officio Trustee Board Member / Chief Executive

    Colin Garner is both a university academic scientist and scientific entrepreneur. He graduated from Chelsea College, University of London (now Kings College) and did his PhD in biochemical toxicology at University College Hospital Medical School. After a two year postdoctoral fellowship at the University of Wisconsin, USA he returned to the UK to carry out cancer research at the University of Leeds and then for the majority of his career at the University of York. He headed up a cancer research laboratory in the Department of Biology for almost 20 years in which time he published over 200 scientific papers and 30 book chapters on the role of gene-environment interactions in cancer causation. Along with two surgeon colleagues, he created the York cancer charity York Against Cancer which provides funds for education, research and patient support.

    Colin founded three University of York spinout companies and is the founder of Antibiotic Research UK. He believe passionately in the new charity and says ‘there is an urgent need to develop new drugs to tackle antibiotic resistant infections as well as educating the public and professionals about antibiotic resistance. Antibiotic Research UK as a charity can make a substantial impact as it is a non-profit organisation. The Charity is working with some of the world’s experts in antibiotic resistance to reach its goal’. Colin was the founder and Director of the Jack Birch Unit for Environmental Carcinogenesis and was an Honorary Professor of Pharmacology at the Hull York Medical School, University of York.

  • Professor Chris G Dowson
    Professor Chris G Dowson
    BSc PhD

    Professor Chris G Dowson (School of Life Sciences, University of Warwick, UK) has, for many years, examined the emergence and evolution of antibiotic resistance across a wide range of bacteria. His recent focus has been to better understand how penicillin targets bacteria. This began during his postdoctoral time at the University of Sussex, in the laboratory of Professor Spratt (1986-1990) and subsequently with his Lister Institute Centenary Fellowship (1991-1996). He currently holds a personal chair at Warwick University and is a past member of the Medical Research Council Infections and Immunity Board.

    Chris’ research is highly collaborative, involving teams of biologists, chemists, engineers and physicists across universities in the UK, worldwide, and all importantly with industry, to help drive innovations from this research forward to a commercial outcome. He was involved with Antibiotic Discovery UK (AD-UK) and has been involved with research fundraising regionally across Warwickshire for the past 16 years with the Medical and Life Sciences Research Fund (MLSRF). He is bringing all of this experience to help develop activities within Antibiotic Research UK.

  • Nick Stalbow of Ashurst LLP
    Nick Stalbow
    Partner, Ashurst LLP
    Interim Chair

    Nick, a graduate of the University of Oxford, is a partner at international law firm, Ashurst LLP, based in the London office. Nick has over twelve years’ experience advising sponsors, commercial banks and funds on major infrastructure projects. He brings his strong, commercial background and experience to the Board of Trustees and, to the extent that the charity needs legal support in its day to day activities, he oversees advice provided by Ashurst on a pro bono basis.

    Nick has a long-standing interest in antibiotic resistance and has been involved with campaigns against the misuse of antibiotics in intensive livestock farming.

  • Erin Lyon

    Erin is a sustainability professional with two decades of experience working with businesses and other stakeholders across the world to tackle the most pressing Environmental, Social and Governance (ESG) challenges.

    Erin is a qualified lawyer by training and has spent her working life in Europe, Asia and the Middle East and is now based in London.

    During her career she has advised multinational companies, non-profits, charities, UN agencies and development banks about the impact of ESG issues on business and the impact of business on ESG issues.   She has also advised financial institutions and other listed companies about the charitable organisations they select to engage with and the measures they use to assess the impact of the partnership.

    Erin says “I became a trustee of ANTRUK as I believe it is imperative we take action on antibiotic resistance immediately.  A multi-sectoral approach is required to meet the global challenge that we face.  I believe that ANTRUK can be a catalyst for action and change”.

  • Tony Farmer
    Partner, Garbutt-Elliott
    Honorary Treasurer

    Tony is Corporate Finance Partner with Garbutt & Elliott, a major regional firm of Chartered Accountants in Yorkshire.  He specialises in mergers and acquisitions, fund raising and financial advisory work.  He has acted as a trustee for many years in education, health care and charitable sectors and has acted as corporate adviser to companies in antibiotic research.  He believes strongly that Antibiotic Research UK is carrying out a vital role in scientific research and development to combat the threat of antibiotic resistance and is delighted to take part in this as a trustee.

  • Professor Christine Bond
    Professor Christine Bond
    Professor of Primary Care and immediate past Head of Centre of Academic Primary Care, University of Aberdeen

    From 1996-2012 Christine was part time Consultant in Pharmaceutical Public Health (NHS Grampian) where she established and chaired the Grampian Primary Care Antibiotic Strategy Group’. She has been awarded well over 100 grants (approximate total grant income >£13million) and has over 250 peer reviewed publications relating to a large portfolio of research on the evidence based cost effective use of medicines (prescribed and ‘OTC’), drug misuse, professional collaborations in primary care and the wider health care agenda.

    Christine is Editor of the International Journal of Pharmacy Practice, was an elected member of the Scottish Board of the Royal Pharmaceutical Society of Great Britain (RPSGB) for 10 years and has served on many national Research Panels eg the Health Service Research Committee of the Scottish Office, the MRC College of Experts, the Scottish Ethics Committee, the RPSGB Pharmacy Practice Research Trust Award panel, the Health Services and Pharmacy Practice Conference Panel.

    She is currently, a member of Pharmacy Research UK Steering Group, and Chair of the Royal Pharmaceutical Society of Great Britain Expert Advisory Panel for Science. In 2010 she was awarded the Pharma’s Lifetime Achievement Award.